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Definite Infective Endocarditis: Clinical and
Microbiological Features of 155 Episodes in 
One Japanese University Hospital
Yoko Takayama,1* Ryoichi Okamoto,2 Keisuke Sunakawa3
Background/Purpose: To evaluate the epidemiology, clinical features, and microbiological features 
(including antibiotic susceptibility) of infective endocarditis (IE) at Kitasato University Hospital, Japan.
Methods: We retrospectively analyzed 153 patients (155 episodes) with definite IE according to the Duke
criteria, who presented over a 17-year period. The minimum inhibitory concentrations of antibiotics for
cultured causative microorganisms were also examined.
Results: Viridans group streptococci were the most common pathogens (36.8%, 57 episodes), followed by
Staphylococcus aureus [21.3%, 33 episodes, including 10 episodes due to methicillin-resistant S. aureus
(MRSA)]. Thirty-nine of the 40 strains of viridans streptococci were fully susceptible to penicillin.
Comparison of IE due to methicillin-sensitive S. aureus (MSSA) and MRSA showed that the latter had a
higher mortality rate (34.8%, 8/23 vs. 70.0%, 7/10). Compared with MSSA, IE caused by MRSA was signif-
icantly more likely to be related to nosocomial infection (10/10, p < 0.001), hemodialysis (4/10, 40.0%,
p = 0.005), and surgery or intravascular catheter insertion (8/10, 80.0%, p = 0.007). There was a signifi-
cantly higher mortality rate in non-operated (15/43, 34.9%) than in operated (2/21, 9.5%) (p < 0.001)
elderly patients. In 92/155 episodes (59.4%), antibiotics were given before blood cultures were obtained.
Culture-negative IE occurred in 20.7% (19/92) of patients on antibiotics versus 6.3% (4/63) of those not
on antibiotics (p = 0.02). Of 155 episodes of IE, 34 (21.9%) were fatal and staphylococcal had significantly
higher mortality than streptococcal IE [(19/40, 47.5%) vs. (7/72, 9.7%); p < 0.001].
Conclusion: The most frequently isolated pathogens were viridans group streptococci, which differed from
other recent studies. In the present study, no penicillin-resistant strains were detected and there was a higher
mortality rate for IE caused by MRSA than MSSA. IE should be considered in MRSA patients with the fol-
lowing risk factors: nosocomial infection, hemodialysis, and surgery or intravascular catheter insertion.
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Despite the availability of new and potent anti-
biotics, modern echocardiography, and advanced
surgical techniques, infective endocarditis (IE) is
still associated with a high mortality rate. The fre-
quency of IE has not decreased over the past few
decades.1,2 Presumably, this is due to the increasing
use of prosthetic valves and permanent pacemak-
ers, an increase in the number of immunocom-
promised patients, longer survival of patients with
congenital heart disease, and more sensitive and
specific diagnostic methods such as echocardiog-
raphy. In contrast, the incidence of rheumatic
valvular disease has decreased. Previous investi-
gations have compared different categories of sub-
jects with IE such as male versus female, young
versus elderly,3,4 culture-positive versus culture-
negative,5 or IE caused by methicillin-sensitive
Staphylococcus aureus (MSSA) versus methicillin-
resistant S. aureus (MRSA).6
A search of MEDLINE from 1966 to the present
using the terms “streptococcus”, “staphylococcus”,
“endocarditis”, and “susceptibility” revealed no
published surveys. There have only been a few
studies on the drug sensitivity profile of viridans
group streptococci, which are the main causative
bacteria of IE.7,8 In the present study, we examined
the antibiotic sensitivity profile of causative micro-
organisms [viridans streptococci, Staphylococcus
aureus, and methicillin-resistant Staphylococcus
epidermidis (MRSE)] in patients with definite IE,
as well as clinical features such as underlying
heart disease and possible sources of infection.
We also compared our findings with previously
published data.
Patients and Methods
Patients
Data were collected on all patients with definite
IE according to the Duke clinical criteria,9 who
were managed at Kitasato University Hospital,
Sagamihara, Kanagawa, Japan (1033 beds). All pa-
tients who were diagnosed with IE from January 1,
1990 to December 31, 2006 were analyzed retro-
spectively by extracting data from their medical
records, including clinical characteristics, predis-
posing factors, intracardiac site of infection, af-
fected heart valve, causative microorganisms, route
of infection, presence of MSSA or MRSA, and out-
come. We defined “nosocomial” as positive culture
samples drawn more than 72 hours after admis-
sion, with no previous indication of infection.6
Bacterial sensitivity testing
We determined the minimum inhibitory concen-
trations (MICs) of 40 strains of viridans strepto-
cocci and 25 strains of MSSA/MRSA/MRSE, which
had been collected and stored at the laboratory of
Kitasato University Hospital. MSSA was defined as
being susceptible to oxacillin (≤ 2 mg/L). MICs
were measured according to the agar dilution
method specified by the Clinical and Laboratory
Standards Institute,10 using plates that contained
Mueller–Hinton agar (Becton Dickinson, Sparks,
MD, USA) supplemented with 5% sheep blood for
viridans streptococci, and Mueller–Hinton agar
alone for MSSA/MRSA/MRSE. A micro-planter for
MIC measurement (Sakuma Seisakusho, Tokyo,
Japan) was used for inoculation, followed by cul-
ture for 20 hours at 35°C in air for MSSA/MRSA/
MRSE, and in an atmosphere of 5% CO2 for 
viridans streptococci. Penicillin G and arbekacin,
cefotiam and cefozopran, flomoxef, cefazolin,
imipenem, azithromycin (AZM) and clindamycin
(CLDM), minocycline, vancomycin (VCM), lev-
ofloxacin, and gatifloxacin were kindly provided
by Meiji Seika (Tokyo, Japan), Takeda Pharma-
ceutical Company (Osaka, Japan), Shionogi &
Company (Osaka, Japan), Astellas Pharma Inc.
(Tokyo, Japan), Banyu Pharmaceutical (Tokyo,
Japan), Pfizer Japan Inc. (Tokyo, Japan), Wyeth K.K.
(Tokyo, Japan), Eli Lilly Japan K.K (Kobe, Japan),
Daiichi Pharmaceutical (Tokyo, Japan), and Kyorin
Pharmaceutical Co., Ltd. (Tokyo, Japan), respec-
tively. Ampicillin (ABPC), gentamycin, and eryth-
romycin (EM) were purchased from Sigma–Aldrich
Japan (Tokyo, Japan).
Prior antibiotic therapy
Patients with IE have often been treated with 
antimicrobial agents before blood cultures are
Y. Takayama, et al
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collected, which frequently leads to either a neg-
ative blood culture or delayed growth that results
in apparent culture-negative IE. We compared 
92 episodes of IE in patients who had received
antibiotics before the first blood cultures were
obtained with 63 episodes of IE in patients who
had not been treated with antibiotics before blood
cultures were collected.
Statistical analysis
Data were analyzed using version 5.0 GraphPad
Prism and results are presented as the median
and interquartile range. Statistical analysis was
performed using the χ2 test and Fisher’s exact
test. A p value < 0.05 was considered to indicate
significance.
Results
General features
All patients were hospitalized for each episode of
IE. One hundred and fifty-five episodes of definite
IE were identified in 153 patients over 17 years,
according to the Duke clinical criteria. Of the
155 episodes, 95 were in male and 60 were in fe-
male patients. The mean age was 49.95±3.14 years
(range, 0–83 years), with a male/female ratio of
1.6. Two patients had more than one episode of
IE (2 each). Fever was the most common symp-
tom (96.8%) at initial evaluation. Other major
symptoms were dyspnea, coma, fatigue, arthral-
gia, headache, and low back pain. The most fre-
quent sign found at the initial examination was
heart murmur (72.9%). Other clinical findings
were proteinuria, hematuria, hepatosplenomegaly,
and neurological deficits. Underlying heart dis-
ease was present in a total of 77 episodes. Mitral
and/or aortic regurgitation was common (32
episodes), but rheumatic heart disease was only
responsible for three episodes. The frequent con-
comitant non-cardiac diseases were malignancy
(16 episodes), diabetes mellitus (14 episodes),
and chronic renal failure (14 episodes). There was
no known underlying disease in 25 episodes. As
shown in Table 1, the infected valve was the mitral,
aortic, and tricuspid in 49.0%, 25.2%, and 9.7%
of episodes, respectively, and multiple valves were
affected in 14 episodes (9.0%). IE involved a na-
tive valve in 147 episodes (94.8%) and a pros-
thetic valve in eight (5.2%). Among the infant
patients, six out of the eight episodes were asso-
ciated with congenital heart disease, and vegeta-
tions were located on the right side of the heart
in five episodes.
Causative microorganisms and probable
source of infection
All of the causative microorganisms were isolated
from blood cultures. The microorganisms identi-
fied in the patients with IE are shown in Table 2.
Blood cultures were positive in 132 out of 155
episodes (85.2%). Streptococcal and staphylo-
coccal infections were predominant. The most fre-
quently isolated pathogens were viridans group
streptococci, which were detected in 57 out of
155 episodes (36.8%). S. aureus was next with 33
episodes (21.3%), of which, 30 episodes oc-
curred after 1994. MRSA endocarditis accounted
for 10 episodes and was only found after 1994.
The presumed source of infection for 17/57 epi-
sodes (29.8%) due to viridans streptococci was
dental treatment, whereas 10/33 episodes (30.3%)
due to S. aureus arose from catheter/wound infec-
tion. Three patients were intravenous drug users,
and all of them had MSSA. Enterococcus was identi-
fied in six episodes; all of which occurred in pa-
tients older than 60 years. There were 23 episodes
of culture-negative IE, and antimicrobial agents
were administered before blood cultures were
Table 1. Affected heart valve
Number of episodes (%)
Mitral valve 76 (49.0)
Aortic valve 39 (25.2)
Tricuspid valve 15 (9.7)
Mitral and aortic valve 12 (7.7)
Pulmonary valve 2 (1.3)
Other 6 (3.9)
Unknown 5 (3.2)
Total 155 (100)
Infective endocarditis at a Japanese hospital
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obtained in 19 of these. Eighteen of the culture-
negative episodes involved the mitral or aortic
valve, eight were suspected to arise from dental
treatment, six patients had no known underlying
diseases, and three died. Overall, the route of 
infection was not determined in 89 of the 155
episodes (57.4%).
Antibiotic sensitivity testing
One of the 40 viridans streptococcus strains
tested (2.5%) showed intermediate penicillin re-
sistance (0.25 mg/L), but the other strains were
fully susceptible (Table 3). The resistant viridans
streptococcus strain was isolated from a patient
with two episodes of IE, and the MICs of ABPC,
cefazolin, cefozopran, EM, AZM, and minocy-
cline were all elevated more than twofold. Four
other strains (10.0%) showed a high level of re-
sistance (≥ 128 mg/L) to EM and AZM, whereas
five (12.5%), six (15.0%), four (10.0%), and one
(2.5%) of the isolated strains were not sus-
ceptible to EM, AZM, CLDM, and VCM, respec-
tively. No penicillin-resistant strains were detected.
As shown in Table 4, the antimicrobial sensitivity
of MSSA to β-lactam agents was generally good,
excluding ABPC. Two of the 25 strains tested
(8.0%) showed a high level of resistance (64 mg/L)
to gentamicin and to AZM, and another two strains
showed intermediate resistance to EM. All of the
MRSA/MRSE strains were sensitive to arbekacin
and VCM.
Elderly IE
We defined elderly IE as episodes in patients over
60 years old. These patients accounted for 48 out
of 87 episodes (55.2%) from 1999 to 2006 versus
16 out of 68 episodes (23.5%) from 1990 to 1998
(p < 0.001). All eight episodes of prosthetic valve
infection and all six of Enterococcus endocarditis
occurred in elderly patients. In the elderly IE group,
the rate of embolic events, heart failure, surgery,
and death was 31.3%, 12.5%, 32.8% and 26.6%,
respectively. There was a significantly higher mor-
tality rate in non-operated elderly patients
(15/43, 34.9%) than in operated elderly patients
(2/21, 9.5%) (p < 0.001).
MSSA IE versus MRSA IE
The characteristics of IE caused by MSSA and
MRSA are compared in Table 5. MSSA infection
was more likely to be community-acquired
(17/23, 73.9%); 10 episodes (43.5%) involved
the mitral valve and seven (30.4%) the tricuspid
valve. As shown in Tables 5 and 6, IE caused by
MRSA tended to occur in patients older than 
60 years (6/10, 60.0%) and was a nosocomial in-
fection (10/10). There was often a delay before
diagnosis (23.6 days), it was related to hemodial-
ysis (4/10, 40.0%), the mortality rate was very high
(7/10, 70.0%), and the mitral valve was usually
affected (8/10, 80.0%). Eight of the 10 episodes
(80%) of MRSA IE occurred after surgery or in-
travascular catheter insertion while the patient
was hospitalized for another condition.
Antibiotic therapy before culture
Antibiotic therapy at the time of blood culture is
shown in the Figure. In 92 of the 155 episodes of
IE (59.4%), the patient received antibiotics be-
fore blood culture was performed. Streptococcal
and staphylococcal infections were predominant
in both groups. Culture-negative IE occurred in
20.7% (19/92) of patients on antibiotics versus
6.3% (4/63) of patients without antibiotic ther-
apy (p = 0.02).
Outcome
Among the 155 episodes of IE, 34 (21.9%) resulted
in death (Table 2). Twenty episodes (58.8%) of IE
led to cerebral fat embolism and/or ruptured my-
cotic aneurysm; among which, eight were due to
S. aureus. Nine episodes of IE progressed to fatal
heart failure (26.4%). Staphylococcal IE had a
significantly higher mortality rate (19/40, 47.5%)
than streptococcal IE (9.7%, 7/72) (p < 0.001,
Table 2).
Discussion
In the present series, IE most commonly affected
middle-aged men, and the mitral valve was in-
volved in 49.0%, compared with a range of
Infective endocarditis at a Japanese hospital
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36–42% in previous studies.1,11 The mitral valve
tends to be slightly predominant in native valve
endocarditis. Our series exhibited a low percent-
age (5.2%, 8 episodes) of PVE patients, whereas it
ranged from 15.9% to 31.0% in other studies.11,12
Involvement of the tricuspid valve was very un-
common in our patients compared with those
from the United States, where there is a higher
percentage of intravenous drug users.6
The most common causative microorganisms
are S. aureus and viridans group streptococci, and
these account for up to 29.8% and 27% of 
community-acquired IE, respectively.2,11 In the pres-
ent series, the overall findings differed from these
results, but the incidence was similar in 1995, 1999
and 2001. An increasing prevalence of S. aureus
has been reported over the past 20 years,2,11 and
we confirmed this in the present study. In fact, 30
out of 33 episodes of IE due to S. aureus occurred
after 1994. In contrast, according to Cicalini et al,
the episodes of IE due to MSSA decreased from
46.2% (61/132) during 1980–1991 to 39.1%
(59/151) during 1992–2003.13 MRSA IE was
only found after 1994 in the present series. Benn
et al also showed that IE caused by MRSA was
not detected between 1984 and 1993.1 However,
Miro et al reported that four out of 43 episodes
of IE due to MRSA occurred before 1990.14 IE
due to Enterococcus was relatively uncommon 
(6 episodes),15,16 with two episodes from 1990 to
1998 and four from 1999 to 2006. In our study,
34 episodes of IE (21.9%) were definitely related
to dental procedures, including 17 that were due to
viridans streptococci, whereas the rate was 23%
in a previous study.17 However, dental procedures
were not found to be a risk factor for IE in another
previous study,18 even in patients with valvular
abnormalities. In 2008, the American College of
Cardiology and American Heart Association re-
vised and updated their existing guidelines for IE
to take account of new data and opinions.19 The
major changes in the updated recommendations
were as follows: the committee concluded that
only an extremely small number of cases of IE can
be prevented by antibiotic prophylaxis for dental
procedures, and that dental prophylaxis is only
Table 5. Characteristics of MSSA versus MRSA infective endocarditis*
MSSA (n = 23) MRSA (n = 10) p
Mean age (yr) 49.3 (39.55–59.06) 51.5 (34.70–68.30) NS
Interval before diagnosis (d) 19.3 (14.28–24.25) 23.6 (15.59–31.61) NS
Nosocomial 6 (26.1) 10 (100) < 0.001
Community acquired 17 (73.9) 0 (0) < 0.001
Hemodialysis 0 (0) 4 (40.0) 0.005
Diabetes mellitus 4 (17.4) 2 (20.0) NS
Operation/catheter 6 (26.1) 8 (80.0) 0.007
Predisposing valvular disease 6 (26.1) 2 (20.0) NS
Valve affected
Mitral 10 (43.5) 8 (80.0) NS
Aortic 6 (26.1) 1 (10.0) NS
Tricuspid 7 (30.4) 1 (10.0) NS
Prosthetic 2 (8.7) 0 (0) NS
Cerebrovascular complications 8 (34.8) 3 (30.0) NS
Surgery 6 (26.1) 2 (20.0) NS
Death 8 (34.8) 7 (70.0) NS
*Data presented as mean (95% confidence Interval) or n (%). MSSA = methicillin-sensitive Staphylococcus aureus; MRSA =
methicillin-resistant Staphylococcus aureus; NS = not significant.
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reasonable for patients who have underlying car-
diac conditions associated with the highest risk
of an adverse outcome of IE.
In the present series, only two patients (1.3%)
experienced a previous episode of IE, compared
with 6–15% in earlier studies.9,17,18 One patient
experienced two episodes of IE caused by viridans
streptococci, and the MIC apparently increased
during the course of treatment. The MIC90 values
for penicillin G (0.125 mg/L), EM (2 mg/L), and
levofloxacin (2 mg/L) for viridans streptococci in
our series were lower than those reported before
(0.5 mg/L, 16 mg/L, and 8 mg/L, respectively),7
whereas the MIC90 values for AZM, CLDM, gat-
ifloxacin and VCM were similar. No penicillin-
resistant strains were detected in our study,
although several case reports of IE due to penicillin-
resistant viridans streptococci have been pub-
lished.20,21 To the best of our knowledge, there
have only been a few previous surveys of the an-
timicrobial sensitivity profile of viridans strepto-
cocci,7,8 and the present study was the first survey
of S. aureus and S. epidermidis.
Endocarditis has increasingly become a disease
of older people. More than half of all cases of IE
in the United States and Europe now occur in pa-
tients age > 60 years, and the median age of IE
patients has increased steadily during the past 40
years.16 This has mainly been attributed to a
marked reduction in the incidence of acute rheu-
matic disease, increasing patients longevity that
has given rise to degenerative valvular lesions,
placement of prosthetic valves, and more frequent
use of invasive central vascular catheters associ-
ated with an increase in nosocomial bacteremia
in western countries.22,23 We also observed an in-
crease in the number of elderly IE patients. How-
ever, according to Heiro et al, no significant
increase was found in the mean age of patients
with IE from 56.3 years during 1995–1999 to 54.5
years during 2000–2004.15 In contrast, a study
from Tunisia reported a mean age of 32.4 years in
patients with IE.22 The low age in the latter study
is comparable to that found in other developing
countries.24,25 The rates of embolic events, heart
failure, surgery, and death were similar to those
in a previous study.26 According to a recent study,
fewer elderly patients undergo cardiac surgery
(38.9% vs. 53.5% for younger patients; p < 0.001),
and elderly patients with IE have a higher hospital
death rate (24.9% vs. 12.8%; p < 0.001).27
Blood culture was negative in 5–49% of IE
patients in previous studies,2,24,28,29 whereas the
rate was 14.8% in the present study. The incidence
Viridans Streptococcus 
Methicillin-sensitive
Staphylococcus aureus
Methicillin-resistant
Staphylococcus aureus
Beta-streptococcus
Staphylococcus epidermidis
Streptococcus sp.
Streptococcus pneumoniae
Enterococcus
Fungi
Others
Culture-negative
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(%)
On antibiotics
Not on antibiotics
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n = 63
Figure. Antibiotic therapy in 92/155 (59.4%) episodes. Patients received antibiotics before blood cultures were obtained
and culture-negative infective endocarditis was more common in this group than when antibiotics were not administered
at the time of blood culture.
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of culture-negative IE varies among countries,
with higher culture-negative rates in developing
countries.
Culture-negative IE can be due to prior anti-
biotic treatment, inadequate microbiological
techniques, fastidious or atypical causative micro-
organisms, and suboptimal blood collection.5
Viridans streptococci might be inhibited from
growing in blood culture by prior antibiotic ther-
apy.30 Serological tests for organisms such as
Coxiella spp., Brucella spp. and Bartonella spp.
might be needed.19 Lamas et al suggested that
the Duke criteria are of limited value for culture-
negative IE.31
S. aureus is one of the most common causes
of IE, and MRSA is becoming an increasingly im-
portant issue. Previous studies have shown that
MSSA and MRSA infections differ in several ways,
including the age of the patients, length of hospi-
tal stay, underlying diseases, prior treatment with
antibiotics, and incidence of shock.7,20 In con-
trast, there were no differences in the outcome of
IE due to MRSA or MSSA in several other studies.6,21
In the present series, there was a higher mortality
rate for IE caused by MRSA (8/23, 34.8%; 7/10,
70.0%) (Table 5); probably because all the MRSA
episodes involved nosocomial infection. Eight epi-
sodes were postoperative or after catheterization
and four occurred in hemodialysis patients.
The high mortality rate of IE due to MRSA
could partly explain the higher overall mortality
rate (40.0%) of our maintenance dialysis patients
compared with that of previous studies (30–
60%).32,33 Nosocomial infection with MRSA might
predispose patients to IE, because Chang et al34
reported that patients with MRSA infection are
significantly more likely to have persistent bacter-
emia than those with IE due to MSSA. Coagulase-
negative staphylococci including S. epidermidis
have become major pathogens that cause IE in
patients with prosthetic heart valves or transve-
nous pacemakers.35 In the present series, there
were six episodes of IE due to MRSE. There was a
history of prosthetic heart valve replacement in
one patient (1 episode). Five episodes of IE were
of unknown origin. The increasing number of
MRSA IE cases is a serious situation. Our data sug-
gest the need for further investigation of the rela-
tionship between sterilization of medical devices
or hand hygiene and the occurrence of MRSA IE in
immunosuppressed patients. This could help to
achieve a decrease in MRSA IE in the future.
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